MAXILUS

A Phase 3b, Open-label Study Evaluating the Efficacy and Safety of Luspatercept (BMS-986346/ACE-536) Initiated at Maximum Approved Dose in LR-MDS With IPSS-R Very Low-, Low-, or Intermediate-risk Who Require RBC Transfusions (MAXILUS)

Near Add Your Location

Cancer and Blood Specialty Clinic
Los Alamitos, CA
  • Accepting patients

Center of Excellence

Smilow Cancer Hospital at Yale New Haven
New Haven, CT
  • Accepting patients

Center of Excellence

University of Kansas Cancer Center
Kansas City, KS
  • Accepting patients
Henry Ford Hospital
Detroit, MI
  • Accepting patients

Center of Excellence

Mount Sinai Hospital
Tisch Cancer Institute
New York, NY
  • Accepting patients

Center of Excellence

West Penn Hospital (Allegheny Health Network)
Pittsburgh, PA
  • Accepting patients
Texas Oncology
Amarillo Cancer Center
Amarillo, TX
  • Accepting patients
499 hidden based on your filters. Show All

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 803-1766

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.